alpha;
Revised Section F: Natural Products and Related Compounds (IUPAC Recommendations 1999)

RF-4.7. Combinations of Prefixes

Continued from RF-4.6 Removal of a Terminal Ring


RF-4.7. Combinations of Prefixes for Modifying a Fundamental Parent Structure

The modifications to a fundamental parent structure prescribed by the prefixes in the preceding recommendations (RF-4.1 through RF-4.4, i.e. excluding bridges, fusion and detachable prefixes) may be combined to effect even more drastic changes in structure. The operation indicated by each prefix is applied to the fundamental parent structure sequentially as one "advances backwards", i.e., moves from right to left, from the name of the fundamental parent structure. The following recommendations are not rigorous rules for choosing a unique name, but are intended to be guidelines for choosing combinations of prefixes and for the order of citation in generating an unambiguous name. error details

RF-4.7.1. When different combinations of prefixes can be used to effect the same transformation in a parent structure, the combination of choice should express the fewest number of operations. Both detachable (e.g. alkyl) and non-detachable (e.g. homo or nor) prefixes are considered as modifications but detachable prefixes are preferred. Dihomo, dinor, etc., are counted as two modifications each [see Rule 3S-6.3 (ref 4)]. When the number of operations is the same, the combination of homo/nor is preferred to cyclo/seco; choice between other combinations expressing the same number of operations is based on earliest alphabetic order of the prefixes. error details

Example:


10(11)a-Homo-9-norergoline
(not (9αH)-5,9-Cyclo-5,10-secoergoline;
another possible alternative name is (9αH)-5(109)-Abeoergoline;
also has been called C(10a)-Homo-D-norergoline) error details

RF-4.7.2. The order of citation of combinations of structure modifying prefixes must avoid improper use of the prefixes as defined above or impossible situations when the corresponding operations are carried out in the manner prescribed above.

Example:


8(14)a,14-Seco-8(14)a-homo-5α-pregnane
(the ring expansion is followed by the bond cleabage; a seco-methyl name might also be used)

RF-4.7.3. (Alternative to RF-4.7.4.) After satisfying RF-4.7.1 and RF-4.7.2, combinations of structure modifying prefixes are cited in alphabetic order from left to right proceeding towards the name of the fundamental structure. Numerical prefixes denoting multiple operations of the same kind do not affect the order.

Examples:


5α-Pregnane
(fundamental parent structure)

13(17)a-Homo-12,18-dinor-5α-pregnane(2S,H,16αH)-7H-1,16:2,4-Dicyclo-3,4-secocorynan error details

9,19-Cyclo-4-nor-5α,9β-cholestane error details11β,18-Cyclo-12a,12b-dihomo-5α-pregnane

Note: The cyclodihomopregnane example above can be named in at least two other ways: (1) 11α,18β-Cyclo-18a,18b-dihomo-5α,13α-pregnane; (2) 11α,13-Propano-18-nor-5α,13α-pregnane. The first name uses the same number of operations, but extends a side chain rather than enlarging a ring (the latter operation seems more usual) resulting in higher locant numbers. The second name uses only one operation of the type discussed in this section, but requires the use of a bridge (see RF-6), which may or may not be considered preferable.

11α,13aα-Cyclo-13(17)a-homo-12-nordammarane error details

RF-4.7.4. (Alternative to RF-4.7.3). After satisfying RF-4.7.1 and RF-4.7.2, the prefixes that indicate bond rearrangements (cyclo, seco, etc.) are followed by those that indicate addition or removal of skeletal atoms (apo, homo, nor). If more than one of any of these operations is needed, they are cited in alphabetic order before the name of the parent structure. Schematically, this order is as follows:

bond rearrangementremoval/addition
of skeletal atoms
Parent
structure
cyclo, secoapo, homo, nor
error details

Examples:


2,4-Seco-3-noroleane
(may be named 3-Nor-2,3-secooleane by RF-4.7.3, above,
which is preferable to 24-Nor-2,3-secooleanane or 3-Nor-3,4-secooleanane on the basis of lower locants)

Estrane
(fundamental parent structure)
7,11α-Cyclo-7,8-seco-17a-homo-5α-estane
(7,11α-Cyclo-17a-homo-7,8-seco-5α-estrane by RF-4.7.3)

Note. This example can also be named (11βH)-7(811)-Abeo-17a-homo-5α-estrane which uses only two operations. error details

(17R,20S)-13,13a-Seco-13(17)a-homo-12-nordammarane error details


References for this section

4. International Union of Pure and Applied Chemistry and International Union of Biochemistry, Joint Commission on Biochemical Nomenclature, "Nomenclature of Steroids, Recommendations 1989", Pure Appl. Chem. 61, 1783-1822 (1989). [also in: Eur. J. Biochem. 186, 429-458 (1989) and pages xxx-lix in Dictionary of Steroids (Hill, R.A., Kirk, D.N., Makin, H.L.J. & Murphy, G.M., eds) Chapman & Hall, London 1991].


Continue with RF-5. Replacement of Skeletal Atoms
Return to Section F: Natural Products home page.
Return to IUPAC chemical nomenclature home page.